Harel Insurance Investments & Financial Services’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-105
Closed -$10K 602
2019
Q2
$10K Buy
105
+15
+17% +$1.42K ﹤0.01% 429
2019
Q1
$8K Sell
90
-15,410
-99% -$1.35M ﹤0.01% 418
2018
Q4
$993K Buy
15,500
+11,244
+264% +$830K 0.06% 84
2018
Q3
$381K Buy
+4,256
New +$376K 0.02% 162
2018
Q1
Sell
-3,000
Closed -$313K 507
2017
Q4
$313K Buy
3,000
+558
+23% +$63K 0.02% 171
2017
Q3
$356K Buy
2,442
+1,500
+159% +$204K 0.03% 124
2017
Q2
$122K Hold
942
0.01% 227
2017
Q1
$118K Buy
+942
New +$113K 0.01% 199
2016
Q3
Sell
-2,692
Closed -$266K 726
2016
Q2
$266K Buy
+2,692
New +$278K 0.03% 131

Other funds holding CELG

Harel Insurance Investments & Financial Services's CELG Position: Q3 2019 in Review

Harel Insurance Investments & Financial Services sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 105 shares — an estimated $10K sold.

Harel Insurance Investments & Financial Services first reported a position in CELG in Q2 2016 and held it in 9 quarters. The position peaked at $993K in Q4 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Harel Insurance Investments & Financial Services reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 105 Celgene Corp shares in Q3 2019, an estimated $10K.
  • Harel Insurance Investments & Financial Services first reported a position in Celgene Corp in Q2 2016 and held it in 9 quarters.
  • Harel Insurance Investments & Financial Services's Celgene Corp position peaked at $993K in Q4 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q3 2019, filed 6 Nov 2019.